Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arcutis Biotherapeutics (ARQT) Return on Sales: 2023-2025

Historic Return on Sales for Arcutis Biotherapeutics (ARQT) over the last 3 years, with Sep 2025 value amounting to -0.14%.

  • Arcutis Biotherapeutics' Return on Sales rose 127.00% to -0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.14%, marking a year-over-year increase of 127.00%. This contributed to the annual value of -0.71% for FY2024, which is 369.00% up from last year.
  • Arcutis Biotherapeutics' Return on Sales amounted to -0.14% in Q3 2025, which was up 60.62% from -0.35% recorded in Q2 2025.
  • Arcutis Biotherapeutics' Return on Sales' 5-year high stood at -0.14% during Q3 2025, with a 5-year trough of -73.35% in Q1 2023.
  • Over the past 3 years, Arcutis Biotherapeutics' median Return on Sales value was -1.60% (recorded in 2024), while the average stood at -10.95%.
  • Data for Arcutis Biotherapeutics' Return on Sales shows a peak YoY soared of 7,114bps (in 2024) over the last 5 years.
  • Arcutis Biotherapeutics' Return on Sales (Quarterly) stood at -5.09% in 2023, then skyrocketed by 438bps to -0.71% in 2024, then surged by 127bps to -0.14% in 2025.
  • Its Return on Sales was -0.14% in Q3 2025, compared to -0.35% in Q2 2025 and -0.61% in Q1 2025.